Page 11 - Read Online
P. 11

Page 6 of 10                                  Kauffmann et al. Mini-invasive Surg 2020;4:54  I  http://dx.doi.org/10.20517/2574-1225.2020.46

                                           Table 4. Histology of resected pancreatic tumors
                         Tumor types                                     Number (%)
                         IPMN, n (%)                                     10 (18.5%)
                         Malignant-IPMN, n (%)                           2 (3.7%)
                         MCN, n (%)                                      10 (18.5%)
                         Malignant-MCN, n (%)                            1 (1.8%)
                         SCA, n (%)                                      17 (31.5%)
                         RCC metastases, n (%)                           1 (1.8%)
                         NET, n (%)                                      9 (16.6%)
                         NEC, n (%)                                      4 (7.4%)
                        IPMN: intraductal papillary mucinous neoplasm; MCN: mucinous cystoadenoma; SCA: serous
                        cystoadenoma; RCC: renal cell carcinoma; NET: neuroendocrine tumor; NEC: neuroendocrine carcinoma


               Table 5. Detailed histology of malignancies
                Tumor types                   Histotype                 T         n      Grading  Ki67 (%)
                Malignant-IPMN
                  Branch duct  Pancreatobiliary, with foci of invasive adenocarcinoma  1  0  -       -
                  Branch duct  Pancreatobiliary, with in-situ adenocarcinoma  -   -         -        -

                Malignant-MCN
                               In-situ cystoadenocarcinoma               -        -         -        -

                NEC
                  1            -                                         3        1         1        1
                  2            -                                         3        1         2        5
                  3            -                                         2        0         2        8
                  4            -                                         2        1         2        7

               IPMN: intraductal papillary mucinous neoplasm; MCN: mucinous cystoadenoma; NEC: neuroendocrine carcinoma

               DISCUSSION
                                                                           [23]
               Minimally invasive distal pancreatectomy is gaining momentum . The technique for minimally
               invasive distal pancreatectomy is indeed less demanding than the one required for minimally invasive
               pancreatoduodenectomy, so that virtually all pancreatic pancreatic surgeons, and most general surgeons,
               can perform this procedure safely in the absence of hostile anatomy and/or advanced tumor stage. However,
                                                                                               [24]
               minimally invasive distal pancreatectomy is a quite rare operation, even at high volume centers , requiring
                                   [25]
               careful patient selection  and the ability to fully master minimally invasive techniques . Patient selection
                                                                                         [26]
               is required to avoid either unnecessary procedures in patients with benign lesions with limited risk of
                                   [27]
               malignant degeneration , or to plan the most appropriate therapeutic strategy for patients with pancreatic
                     [28]
               cancer . Mastering of surgical technique is required to adapt the procedure to tumor type, and to face
               complex intraoperative scenarios that are sometimes unexpected. Minimally invasive spleen preserving
               distal pancreatectomy is the perfect example of this paradigm as it requires both extra careful patient
               selection and fine surgical technique. The robot, in competent hands, is a useful tool to improve surgical
               precision and maximize the rate of spleen preservation. However, it cannot surrogate for competency and
               basic surgical technique. Preservation of the spleen along with the splenic vessels requires fine dissection
               and the ability to safely manage small pancreatic vessels. The learning curve for this procedure has not
               been defined but is expected to be longer than the one reported for distal pancreatectomy with en-bloc
                          [15]
               splenectomy . So far, unfortunately, there is also no validated program for systematic training of novices.
               While International Societies are working on these programs, background experience with other robotic
               procedures, video review, procedure observation, on-site proctoring (possibly using the dual console), and
               careful selection of patients are all believe to be important to permit safe implementation of a program for
               RA-SPDP.
   6   7   8   9   10   11   12   13   14   15   16